Deferred Tax Assets, Valuation Allowance of HALOZYME THERAPEUTICS, INC. from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
HALOZYME THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • HALOZYME THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $878,000, a 63% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

HALOZYME THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $878,000 -$1,485,000 -63% 31 Dec 2025 10-K 17 Feb 2026 2025 FY
Q4 2024 $2,363,000 -$225,000 -8.7% 31 Dec 2024 10-K 17 Feb 2026 2025 FY
Q4 2023 $2,588,000 +$1,881,000 +266% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q4 2022 $707,000 +$207,000 +41% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q4 2021 $500,000 -$199,327,000 -100% 31 Dec 2021 10-K 21 Feb 2023 2022 FY
Q4 2020 $199,827,000 +$44,727,000 +29% 31 Dec 2020 10-K 22 Feb 2022 2021 FY
Q4 2019 $155,100,000 +$8,147,000 +5.5% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q4 2018 $146,953,000 +$20,764,000 +16% 31 Dec 2018 10-K 24 Feb 2020 2019 FY
Q4 2017 $126,189,000 -$77,181,000 -38% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q4 2016 $203,370,000 +$20,863,000 +11% 31 Dec 2016 10-K 20 Feb 2018 2017 FY
Q4 2015 $182,507,000 +$3,542,000 +2% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q4 2014 $178,965,000 +$16,997,000 +10% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q4 2013 $161,968,000 +$33,525,000 +26% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q4 2012 $128,443,000 +$20,954,000 +19% 31 Dec 2012 10-K 28 Feb 2014 2013 FY
Q4 2011 $107,489,000 31 Dec 2011 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.